Sayer Ji pushes retracted anti-vaccine articles – cause

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
180
Sayer Ji pushes retracted anti-vaccine articles – cause he’s got nothing

https://www.skepticalraptor.com/skepticalrapt...t-nothing/



Sayer Ji is the founder of the pseudoscience pushing website GreenMedInfo. Ji is a slightly different version of Mike Adams who runs his own pseudoscience pushing website, Natural News. To be honest, if you read a random article from either one, they sound alike, and they promote the same junk science. In case you wondering, they hate vaccines for all the same gibberish reasons that are pushed by all anti-vaccine websites.

So what is Sayer Ji saying today? Well he’s pushing some nonsense conspiracies about Anthony R Mawson’s anti-vaccine papers. And if you don’t recall who Dr. Mawson is, he’s the brainless researchers had a paper retracted.

Then resubmitted that same paper and got it retracted again. What makes these retractions juicily ironic is that they were both retracted by awful predatory journals.

Mawson’s article was published for the first time in Frontiers in Public Health, a part of the Frontiers Media empire. It was published for the second time in the Journal of Translational Science, a part of OAT. Both Frontiers Media and OAT are predatory publishers according to the definitive Beall’s List.

A predatory publisher is an “exploitative open-access publishing business model that involves charging publication fees to authors without providing the editorial and publishing services associated with legitimate journals.”


I never have written about it, but there’s a second article written by Anthony Mawson, “Preterm birth, vaccination and neurodevelopmental disorders: a cross-sectional study of 6- to 12-year-old vaccinated and unvaccinated children,” also published in OAT’s Journal of Translational Science JTS).

Go ahead, look for that article, I’ll wait. Oh, Google is of no help? I forgot to mention but that article was also scrubbed from the JTS website, just like Mawson’s other articles. Well, if you’re really interested in the article, because the internet never forgets, here it is.

In case you’re wondering, this other article uses the same data, same techniques, and same bogus conclusions as the double-retracted article. Let’s take a quick look.

Why these articles are bad?

1.Because the journals in which they were published are bad. Frontiers in Public Health (FPH) is not indexed in PubMed. And the Journal of Translational Science (JTS) is not indexed in PubMed. PubMed is one of the most valued resources in searching for biomedical articles, even in obscure journals.

Both FPH and JTS lack an impact factor. As we mentioned above, both FPH and JTS are published by predatory publishers (one of the possible reasons that the journals are not indexed). There is nothing positive to say about these journals.

2.I wrote previously about what makes these articles so bad, but here’s a quick review. They use questionnaires instead of medical records, which brings in parental confirmation and observation bias to the research. The questionnaires only target home schooled children an internally biased group. Small study population. And many more issues.

A real study to compare vaccines effects is generally a meta-review (at the top of the hierarchy of scientific evidence) of several large epidemiological case-control and cohort studies.

For example, this study, by LE Taylor et al., included five cohort studies involving 1,256,407 children, and five case-control studies involving 9,920 children.

It examined the possibility of links between vaccination and autism, MMR vaccine and autism, and thimerosal and autism. (A more detailed analysis of this article can be found here.) This was a huge, well-designed systematic review that found a simple conclusion –

Findings of this meta-analysis suggest that vaccinations are not associated with the development of autism or autism spectrum disorder. Furthermore, the components of the vaccines (thimerosal or mercury) or multiple vaccines (MMR) are not associated with the development of autism or autism spectrum disorder.

Dr. Mawson actually has the background to run a well-designed study such as this one. Why doesn’t he, instead putting together studies so bad that even junk science journals retract them?

Apparently, he’s trying to find data that supports his preconceived conclusions about vaccines, which is really just how pseudoscience works.


Those of us who are pro-science tend to gather high quality data published in real high quality journals, and see where it leads us. And unless you only believe in studies in awful journals, then any rational mind would see that the overwhelming scientific evidence continues to show us that vaccines are relatively safe. And they most certainly are not involved with neurodevelopmental disorders.


Scroll down for more posts ▼

Top 10 Most Recent News Articles

SHOEBOX PureTest Wins 2026 Award for Audiometry Innovation

Updated Category News Views 4

Breaking New Ground in Hearing Conservation This time, we're looking at SHOEBOX PureTest snagging the 2026 Hearing Technology Innovator Award. It marks yet another feather in their cap, standing tall in the Equipment, Audiometry category. You know, for those of us knee-deep in the stock game—and I mean neck-deep in financial stakes—spotting a company thriving through...

Continue Reading
OTconnect on Apple Watch: A New Fitness Era Dawns

Updated Category News Views 6

What’s Orangetheory Up To Now? Ah, fitness gadgets, where everyone’s seemingly got a scheme brewing. This time it's Orangetheory (OTF), turning your Apple Watch into your new best gym buddy. October 22, 2026, marks the launch of OTconnect for Apple Watch, offering a slick way for enthusiasts to tune into their own sweat metrics. If you’re already an Apple Watch...

Continue Reading
AceMyNursingExams Debuts Versatile Nursing Prep Platform

Updated Category News Views 4

A Digital Lifeline for Nursing Students Nursing students are buried in responsibilities: lectures, clinical rotations, and sometimes even a job to fund the whole marathon. And just when they think they’ve got it handled, boom, a mountain of exams rises up in front of them. AceMyNursingExams gets this, rolling out an online exam prep platform to keep these future...

Continue Reading
MLS Org's Sue Compass to Safeguard Fair Listing Access

Updated Category News Views 5

Real Estate Clash: MLS vs. Compass Imagine flipping on the TV to see a legal showdown brewing in the real estate world — you've got six heavy-hitter MLSs facing off against Compass, Inc. Yeah, we're talking a legal slugfest here, folks, as these MLSs rally to keep the playing field level for over 120,000 agents across the country. They're not messing around, bringing a...

Continue Reading
Carrier Drops $600M on U.S. Manufacturing Boost

Updated Category News Views 7

A Mighty Move in Manufacturing Carrier Global Corporation's recent muscle-flexing is something rarer than a golden goose in today's market—a $600 million thrust into beefing up U.S. manufacturing and engineering. You can't help but wonder if this is overzealous optimism or a meticulously calculated power play. Clocks don't tick this loudly without good reason, of...

Continue Reading
College Athletics Needs a New Business Revolution

Updated Category News Views 3

Wake Up Call for College Athletics Here's a heads-up—college sports aren't just about cheering fans and game-day jerseys anymore. It's high time universities start thinking of athletics as businesses, blending the thrill of game day with the realities of financial statements. Michael Schreiber rang this bell loud and clear on the 'Disruption Interruption' podcast,...

Continue Reading
Oak View Group Partners with Payactiv for Employee Benefits

Updated Category News Views 9

Bringing Financial Flexibility to Venue Employees Oak View Group (OVG) has taken a bold step toward enhancing the financial lives of its workforce. They’ve teamed up with Payactiv, the trailblazer in Earned Wage Access (EWA), to deliver a more flexible way for their employees to access funds they've already earned. This move stretches across more than 40 locations...

Continue Reading
ImmVira's Bladder Cancer Trials: Promising Data Revealed

Updated Category News Views 0

Tackling Bladder Cancer with Innovation In a world where every budding biotech claims they're on the cusp of revolutionizing cancer treatment, ImmVira's recent data on their oncolytic immunotherapy, MVR-T3011, stands out like a bright flash in a murky market. Presented at the prestigious European Society for Medical Oncology (ESMO) Congress 2026 in Suzhou, these updates...

Continue Reading
Lennox-Gastaut Syndrome: Unseen Struggles and Hope Ahead

Updated Category News Views 4

Asking the World to See LGS Life throws curveballs, but Lennox-Gastaut Syndrome (LGS) comes barreling down like a freight train in the quiet. It's a rare form of epilepsy that sows chaos in young lives with relentless seizures, leaving families in a fog of uncertainty and heartbreak for years. On International LGS Awareness Day™, November 1, families and advocates are...

Continue Reading
Ping An Good Doctor Grows 35%: AI's Expanding Role

Updated Category News Views 2

Ping An Good Doctor's Noteworthy Financial Uptick Stop me if you've heard this one: a hefty hike in numbers that make investors straighten up a bit. Ping An Good Doctor did just that, reporting a 35% spark in net profit as the books closed up till September 2026. In a landscape where many health-tech firms merely tread water, these guys rode a wave of RMB 0.25 billion in...

Continue Reading

Top 5 Most Recently Viewed Articles

Investor Alert: Edwards Lifesciences Faces Class Action Lawsuit

Updated Category News Views 238

Edwards Lifesciences and the Class Action Lawsuit Investors are being urged to take note of an important upcoming deadline concerning a class action lawsuit involving Edwards Lifesciences Corporation (NASDAQ: EW). With significant events unfolding within the company and its stock performance, it's crucial for investors to stay informed and consider their options...

Continue Reading
Charlotte's Web Plans 2024 Fourth Quarter Earnings Call

Updated Category News Views 235

Charlotte's Web Sets Stage for 2024 Fourth Quarter Earnings Call Charlotte's Web Holdings, Inc. is excited to announce its upcoming earnings call scheduled for March 19, 2025. This call will cover the company’s fourth-quarter and year-end results, presenting an overview of their successes and future strategies in the competitive cannabidiol (CBD) market. Details of the...

Continue Reading
Erma's at Fairmont: A Bold Move in Affordable Housing

Updated Category News Views 12

Affordable Housing Takes a Stand in Salt Lake City Picture this: a groundbreaking ceremony not just for a construction project, but a significant step toward addressing an acute affordability problem right in the heart of Salt Lake City. Lincoln Avenue Communities (LAC), along with the Housing Authority of Salt Lake City (HASLC), is rolling the dice on Erma's at...

Continue Reading
Holley Performance Brands Set for Q4 2024 Earnings Call

Updated Category News Views 122

Overview of Holley’s Upcoming Earnings Call Holley Performance Brands (NYSE: HLLY), a prominent name in automotive aftermarket performance solutions, has announced a significant event for its stakeholders. The company is gearing up to reveal its fourth quarter and full year financial results, marking an important moment for its investors and enthusiasts alike. Key...

Continue Reading
Important Notice for Humacyte, Inc. Shareholders on Class Action

Updated Category News Views 192

Key Information for Shareholders of Humacyte, Inc. The Gross Law Firm is reaching out to shareholders of Humacyte, Inc. (NASDAQ: HUMA) following significant developments in a lawsuit pertaining to the company. This notice aims to inform shareholders about crucial steps they can take regarding their investments and potential participation in this class action....

Continue Reading